144 related articles for article (PubMed ID: 1713216)
1. Human immunodeficiency virus reverse transcriptase. Effect of primer length on template-primer binding.
Reardon JE; Furfine ES; Cheng N
J Biol Chem; 1991 Jul; 266(21):14128-34. PubMed ID: 1713216
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.
Reardon JE; Miller WH
J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 reverse transcriptase: polymerization properties of the p51 homodimer compared to the p66/p51 heterodimer.
Bavand MR; Wagner R; Richmond TJ
Biochemistry; 1993 Oct; 32(40):10543-52. PubMed ID: 7691176
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching.
Huber HE; McCoy JM; Seehra JS; Richardson CC
J Biol Chem; 1989 Mar; 264(8):4669-78. PubMed ID: 2466838
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the p51 subunit of HIV-1 reverse transcriptase to enzyme processivity.
Huang SC; Smith JR; Moen LK
Biochem Biophys Res Commun; 1992 Apr; 184(2):986-92. PubMed ID: 1374247
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of template.primer interactions with recombinant forms of HIV-1 reverse transcriptase.
Beard WA; Wilson SH
Biochemistry; 1993 Sep; 32(37):9745-53. PubMed ID: 7690592
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of primers and templates in the synthesis of DNA catalyzed by human immunodeficiency virus type 1 reverse transcriptase.
Nevinsky GA; Andreola ML; Jamkovoy VI; Levina AS; Barr PJ; Tarrago-Litvak L; Tharaud D; Litvak S
Eur J Biochem; 1992 Jul; 207(1):351-8. PubMed ID: 1378404
[TBL] [Abstract][Full Text] [Related]
8. Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase.
Andreola ML; Tarrago-Litvak L; Levina AS; Kolocheva TI; el Dirani-Diab R; Jamkovoy VI; Khalimskaya NL; Barr PJ; Litvak S; Nevinsky GA
Biochemistry; 1993 Apr; 32(14):3629-37. PubMed ID: 7682110
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase.
Souquet M; Restle T; Krebs R; Le Grice SF; Goody RS; Wöhrl BM
Biochemistry; 1998 Sep; 37(35):12144-52. PubMed ID: 9724526
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
Jaju M; Beard WA; Wilson SH
J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
[TBL] [Abstract][Full Text] [Related]
11. Interaction of primer tRNA(Lys3) with the p51 subunit of human immunodeficiency virus type 1 reverse transcriptase: a possible role in enzyme activation.
Zakharova OD; Tarrago-Litvak L; Fournier M; Andreola ML; Repkova MN; Venyaminova AG; Litvak S; Nevinsky GA
FEBS Lett; 1995 Mar; 361(2-3):287-90. PubMed ID: 7535248
[TBL] [Abstract][Full Text] [Related]
12. Mutating the "primer grip" of p66 HIV-1 reverse transcriptase implicates tryptophan-229 in template-primer utilization.
Jacques PS; Wöhrl BM; Ottmann M; Darlix JL; Le Grice SF
J Biol Chem; 1994 Oct; 269(42):26472-8. PubMed ID: 7523408
[TBL] [Abstract][Full Text] [Related]
13. Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer.
Ding J; Jacobo-Molina A; Tantillo C; Lu X; Nanni RG; Arnold E
J Mol Recognit; 1994 Jun; 7(2):157-61. PubMed ID: 7530020
[TBL] [Abstract][Full Text] [Related]
14. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
Canard B; Sarfati SR; Richardson CC
J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the RNA-directed DNA polymerase activity of a recombinant HIV-1 p51 reverse transcriptase by a p15 ribonuclease H domain.
Evans DB; Kézdy FJ; Tarpley G; Sharma SK
Biotechnol Appl Biochem; 1993 Feb; 17(1):91-102. PubMed ID: 7679907
[TBL] [Abstract][Full Text] [Related]
16. Substrate inhibition of the human immunodeficiency virus type 1 reverse transcriptase.
Furman PA; Painter G; Wilson JE; Cheng N; Hopkins S
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6013-7. PubMed ID: 1712479
[TBL] [Abstract][Full Text] [Related]
17. A higher affinity of AMV reverse transcriptase for template-primers correlates with a lower rate of DNA synthesis.
Parnaik VK; Das MR
FEBS Lett; 1983 Sep; 161(1):145-8. PubMed ID: 6193009
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human immunodeficiency virus 1 reverse transcriptase by 3'-azidothymidine triphosphate.
Heidenreich O; Kruhøffer M; Grosse F; Eckstein F
Eur J Biochem; 1990 Sep; 192(3):621-5. PubMed ID: 1698626
[TBL] [Abstract][Full Text] [Related]
19. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
[TBL] [Abstract][Full Text] [Related]
20. Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha-helix in the thumb subdomain.
Beard WA; Stahl SJ; Kim HR; Bebenek K; Kumar A; Strub MP; Becerra SP; Kunkel TA; Wilson SH
J Biol Chem; 1994 Nov; 269(45):28091-7. PubMed ID: 7525566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
